NASHVILLE, Tenn., July 2 /PRNewswire/ -- Ambulatory Services of America, Inc. announced the formation of ROSA of North Dallas, LLP, its sixth joint venture to provide outpatient radiation oncology services. ROSA of North Dallas is a joint venture between ASA's subsidiary, Radiation Oncology Services of America, and some of the former owners of Landmark Radiation Dallas LP. ROSA of North Dallas will own and operate Northpoint Cancer Center in Dallas, Texas, which was previously owned and operated by Landmark Radiation Dallas.
(Logo: http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO)
ROSA of North Dallas will offer state-of-the-art cancer treatment services, including intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) in the Dallas center. The joint venture expects to build on Landmark Radiation's legacy of providing high-quality cancer care to the residents of the north Dallas area. Edward Gilbert, M.D. will serve as medical director for ROSA of North Dallas, and Dr. Timothy Nichols will also continue to provide professional radiation oncology services at the facility.
Dr. Gilbert said, "We look forward to working with Ambulatory Services of America and Radiation Oncology Services of America to provide a full range of radiation therapy services to patients in North Dallas. We are pleased to have worked with Landmark Radiation to build the North Dallas center and look forward to a long relationship with ASA and ROSA."
Timothy Martin, President and Chief Executive Officer of ASA, said, "We
are excited to expand our presence in the Dallas area and Texas generally.
With the formation of ROSA of North Dallas, we now own and operate three
radiation oncology centers in Texas, with two in the Dallas metropolitan
area. We look forward to working with our new affiliated physicians to
provide high quality care to canc
'/>"/>
| SOURCE Ambulatory Services of America, Inc. Copyright©2008 PR Newswire. All rights reserved |